Recordati Industria Chimica e Farmaceutica SpA
F:RER1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
F:RER1
|
IT |
|
Odfjell SE
F:O7F
|
NO |
Intrinsic Value
The intrinsic value of 
Recordati Industria Chimica e Farmaceutica SpA (RER1) under the Base Case is 61.85 EUR per share.
Compared with the current market price of 52.9 EUR, the stock appears
Undervalued by 14% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Recordati Industria Chimica e Farmaceutica SpA Does
Recordati Industria Chimica e Farmaceutica is an Italian pharmaceutical company that develops, manufactures, and sells branded medicines. Its portfolio includes prescription drugs for specialty and rare conditions, along with some consumer healthcare products. It does not mainly sell generic bulk medicine; instead, it focuses on specific treatments where doctors, pharmacies, and hospitals need reliable branded products.
- Headquarters
- Italy IT
- Employees
- 4 654
- IPO date
- Jan 1, 1984
Revenue & Expenses Breakdown
Recordati Industria Chimica e Farmaceutica SpA
Earnings Waterfall
Recordati Industria Chimica e Farmaceutica SpA
The intrinsic value for Recordati Industria Chimica e Farmaceutica SpA (RER1) under the Base Case is 61.85 EUR.
Compared with the current market price of 52.9 EUR, the stock appears Undervalued by 14% .